Table 2. Univariate analysis assessing... | American Society of Hematology

Table 2.

Univariate analysis assessing OS and PFS

Variable	OS, HR (95% CI)	P	PFS, HR (95% CI)	P
Age*	1.14 (1.05-1.24)	.002	1.03 (1.00-1.05)	.06
Male sex	0.45 (0.08-2.69)	.39	0.56 (0.23-1.34)	.19
Bulky disease	0.59 (0.06-4.40)	.53	1.32 (0.54-3.24)	.54
CMT	0.45 (0.07-2.82)	.39	0.26 (0.09-0.71)	.009
PET2-positive†
DS ≥3	4.06 (0.57-28.98)	.16	5.12 (1.97-13.31)	<.001
DS ≥4	7.72 (1.07-55.56)	.04	11.53 (4.40-30.21)	<.001
Unfavorable disease	0.11 (0.02-1.51)	.11	0.21 (0.02-2.29)	.20

Variable	OS, HR (95% CI)	P	PFS, HR (95% CI)	P
Age*	1.14 (1.05-1.24)	.002	1.03 (1.00-1.05)	.06
Male sex	0.45 (0.08-2.69)	.39	0.56 (0.23-1.34)	.19
Bulky disease	0.59 (0.06-4.40)	.53	1.32 (0.54-3.24)	.54
CMT	0.45 (0.07-2.82)	.39	0.26 (0.09-0.71)	.009
PET2-positive†
DS ≥3	4.06 (0.57-28.98)	.16	5.12 (1.97-13.31)	<.001
DS ≥4	7.72 (1.07-55.56)	.04	11.53 (4.40-30.21)	<.001
Unfavorable disease	0.11 (0.02-1.51)	.11	0.21 (0.02-2.29)	.20

Age evaluated per increasing 1-year increments.

Assessed from date of PET-2 scan to date of event.